• Home »
  • Site Essentials »
  • Site-Map

Site Map

  • Home
    • About Us
      • Mission & Strategy
      • Research & Development
      • Manufacturing
      • Supply Chain Management
      • Careers
        • UK
        • Switzerland
        • France
      • Board of Directors
        • Frank Condella
        • Dr. Ken Cunningham
        • Peter Grant
        • Alan Bray
        • Jean-Charles Tschudin
        • Dr Thomas Werner
        • Dr. Axel Müller
      • Executive Management
        • Peter Grant
        • John Murphy
        • Tim McBride
        • Dr. Kirsten Kaiser
        • Dr. Anne Brindley
        • Dr. Axel Müller
    • Products
      • Approved Products
        • Inhalation Products
          • Pulmicort
        • Oral Products
          • Sular
          • Triglide
          • Lodotra
          • Paxil Controlled Release
          • Xatral Once Daily
          • Coruno
          • Madopar Dual Release
          • Diclofenac
          • ZYFLO
          • Requip XL
        • Topical Products
          • Solaraze
      • Pipeline Products
        • Inhalation Products
          • Flutiform
        • Oral Products
          • Lodotra
    • Technology
      • Inhalation Technology
        • Inhalation Devices
          • Metered Dose Inhalers
          • Dry Powder Inhalers
        • Formulation Technologies
          • Metered Dose Inhalers
          • Dry Powder Inhalers
      • Oral Technology
        • Geoclock
        • Geomatrix
          • Release Control mechanisms
        • Medicated Chewing Gum
        • Particle Engineering Technologies
          • Insoluble Drug Delivery Platform
          • DissoCubes
    • Partnering
    • Investors
      • Financial Information
      • Press Releases
      • Shares
      • Presentations & Webcasts
      • Calendar
      • Analysts
      • Corporate Advisers
      • Corporate Governance
      • Corporate Social Responsibility
      • Email Alerts
      • Warning to Shareholders
    • Contact Us

Copyright 2009, SkyePharma. All Rights Reserved.

SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom

  • Site-Map
  • Terms & Conditions
  • Privacy Policy

© 2010 SkyePharma | Contact Us | Privacy Policy | Site-Map | Terms & Conditions

Content | Menu | Top

  • Home
  • About Us
    • Mission & Strategy
    • Research & Development
    • Manufacturing
    • Supply Chain Management
    • Careers
      • UK
      • Switzerland
      • France
    • Board of Directors
      • Frank Condella
      • Dr. Ken Cunningham
      • Peter Grant
      • Alan Bray
      • Jean-Charles Tschudin
      • Dr Thomas Werner
      • Dr. Axel Müller
    • Executive Management
      • Peter Grant
      • John Murphy
      • Tim McBride
      • Dr. Kirsten Kaiser
      • Dr. Anne Brindley
      • Dr. Axel Müller
  • Products
    • Approved Products
      • Inhalation Products
      • Oral Products
      • Topical Products
    • Pipeline Products
      • Inhalation Products
      • Oral Products
  • Technology
    • Inhalation Technology
      • Inhalation Devices
      • Formulation Technologies
    • Oral Technology
      • Geoclock
      • Geomatrix
      • Medicated Chewing Gum
      • Particle Engineering Technologies
  • Partnering
  • Investors
    • Financial Information
    • Press Releases
    • Shares
    • Presentations & Webcasts
    • Calendar
    • Analysts
    • Corporate Advisers
    • Corporate Governance
    • Corporate Social Responsibility
    • Email Alerts
    • Warning to Shareholders
  • Contact Us